AlphaYouPP
Insider selling
Paul Peter Tak sold $3.2M of Candel Therapeutics, Inc. (CADL) stock
Paul Peter Tak, Chief Executive Officer of Candel Therapeutics, Inc. (CADL), sold 280,245 shares of CADL stock worth $3.2M, per an SEC Form 4 filed Sep 11, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 10, 2026, 1 day before it was made public.
CADL has moved -4.2% since the trade date, from $11.33 to $10.85 (Sep 18, 2026 close).
- Traded
- Sep 10, 2026
- Disclosed
- Sep 11, 2026
- Filing delay
- 1 day
- Price since
- -4.2%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More CADL insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.